PolfaWarszawa
Updating the operating model
- Biotechnology
- January 2026
A4BEE prepared this analysis from publicly available sources. It reflects our own reading of PolfaWarszawa's published strategy and is not endorsed by, or produced in cooperation with, PolfaWarszawa. Company website
Strategic priorities
PolfaWarszawa operates across 4 stated priorities, with the most concrete near-term plan anchored on factory of the future (industry 4.0).
Implementation of Industrial IoT, Machine Learning, and Digital Twins through the Polpharma-Microsoft MoU to transform manufacturing operations into a data-driven, automated production environment with real-time process visibility.
Digitization of the entire value chain starting from R&D laboratories, integrating disparate devices and creating unified data platforms to accelerate drug development and enable real-time process intelligence.
Establishment of Rezon Bio with mirrored capabilities between Gdańsk and Duchnice facilities to provide cost-efficient biologics manufacturing services with smooth technology transfer for global clients.
-
01
Factory of the Future (Industry 4.0)
Implementation of Industrial IoT, Machine Learning, and Digital Twins through the Polpharma-Microsoft MoU to transform manufacturing operations into a data-driven, automated production environment with real-time process visibility.
-
02
100% Digital Lab and TechBio Shift
Digitization of the entire value chain starting from R&D laboratories, integrating disparate devices and creating unified data platforms to accelerate drug development and enable real-time process intelligence.
-
03
CDMO Excellence and Scale-Up
Establishment of Rezon Bio with mirrored capabilities between Gdańsk and Duchnice facilities to provide cost-efficient biologics manufacturing services with smooth technology transfer for global clients.
-
04
ESG and Decarbonization by 2025
Achievement of 17% reduction in Scope 1 and 2 GHG emissions through transition from coal-fired steam production to biomass/gas, implementing Ecodesign principles for all new drugs.
Challenges we see
- Operations Manufacturing
Mass Decommissioning and Site Migration
The transition from the historic Karolkowa Street complex to the new Duchnice facility requires recreating highly sensitive sterile environments while maintaining business continuity for life-saving medicines like Acard and ophthalmic products.
Historical signals from similar pharma construction projects (Polfa Tarchomin) indicate supply chain problems and macroeconomic headwinds causing coordination difficulties between internal and installation works.
- Digital Integration
Joining records across systems
Despite high-level Industry 4.0 vision, day-to-day operations rely on paper-based batch records leading to human error, omissions, and quality review processes taking days or weeks.
Shop-floor data (OT) is not effectively integrated with business management systems (IT), preventing real-time visibility into production performance and creating compliance risk.
- Digital Integration
IT/OT Convergence Gap
While Polpharma has piloted Digital Twin projects using PTC and Rockwell technologies in Starogard Gdański, this level of maturity is not uniform across facilities, particularly for the new Duchnice site.
Many mature manufacturing plants contain air-gapped legacy machines without native connectivity, requiring manual USB data transfer which poses cybersecurity risks.
- Compliance Regulatory
HPAPI Containment and Safety Monitoring
The production of highly potent active pharmaceutical ingredients (HPAPI) in Project Prometheus requires high-performing containment technologies to protect personnel from exposure.
Technical complexity of integrating isolators and secondary protection solutions with legacy airflow and utility systems requires sophisticated digital oversight that current infrastructure is not yet set up to provide.
- Operations Manufacturing
Multi-Site Technology Transfer Synchronization
Rezon Bio's CDMO value proposition depends on mirrored capabilities between Gdańsk and Duchnice facilities for global clients requiring smooth technology transfer.
Any discrepancy in equipment calibration or data latency between sites represents a friction point that could undermine client confidence and contract retention.
Opportunities, by urgency and business impact
Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.
-
Real-Time Bioprocess Visibility Gap
Scientists at Polfa/Polpharma laboratories suffer from data latency where critical insights are only available days after experiments via offline Excel reports. Key metrics like CSPR require integrating data from multiple disjointed sources.
Implement unified dashboards combining online and offline data with automated KPI calculations, enabling "Golden Batch" comparisons in real-time to accelerate process optimization.
-
Digital Hesitancy and Cultural Resistance
Long-tenured employees exhibit a "Trust Deficit" toward digital systems, preferring paper notebooks and USB drives. The "Paper Habit" is deeply ingrained, with operators keeping automation systems in "Manual Mode" due to "Black Box Anxiety."
Deploy UX-driven redesign of legacy interfaces combined with structured onboarding programs and "Sandbox" environments to build trust and decrease transition time to digital workflows.
-
Legacy Equipment Data Isolation
Many legacy machines are air-gapped and lack native connectivity. Data must be manually transferred via USB, creating cybersecurity vulnerabilities and preventing the creation of a comprehensive digital nervous system.
Execute a "Digital Resurrection" strategy using vendor-agnostic integration to connect diverse instruments from multiple vendors (Beckman Coulter, Roche, Hamilton) into a secure, unified data platform.
-
Sustainability Data Transparency Gap
Polpharma must achieve 17% CO2 reduction by 2025 and implement Ecodesign for all new drugs, but legacy systems cannot support the real-time monitoring and energy efficiency audits required.
Build an ontology-based Industrial Data Platform that automates carbon footprint calculations per kg of product by integrating utility data (OT) with production volumes (IT).
-
CDMO Technology Transfer Risk
Rezon Bio must prove reliability to global clients through smooth mirrored capabilities between Gdańsk and Duchnice. Any calibration discrepancy or data latency risks contract losses and reputational damage.
Implement MTP-based modular production with real-time bioprocess monitoring to enable rapid reconfiguration for different CDMO clients while ensuring validated data integrity across sites.
What we'd propose
- Digital Lab
Real-Time Bioprocess Intelligence Platform
A comprehensive data visualization and KPI automation system that transforms raw bioreactor data into actionable biological insights through intuitive dashboards mirroring P&ID layouts.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital Lab
Digital Adoption and Change Management Program
A comprehensive cultural transformation initiative combining UX-driven interface redesign with structured onboarding paths to convert "Digital Hesitancy" into active digital engagement.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital Lab
Lab System Integration and Digital Nervous System Restoration
A vendor-agnostic integration solution that connects legacy and modern laboratory equipment into a unified, secure data platform with comprehensive OT/IT convergence.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Enterprise AI
Industrial Data Platform for Sustainability Compliance
An ontology-based data platform that automates sustainability reporting by integrating utility systems with production data to calculate carbon footprint per unit of output.
-
Ontology layer
DETAIL
-
Predictive models
DETAIL
-
Decision surfaces
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital CDMO
MTP-Based Modular Production for CDMO Excellence
Implementation of Module Type Package standards to enable rapid reconfiguration of mammalian cell culture lines while ensuring validated data integrity across mirrored facilities.
-
OT/IT convergence
DETAIL
-
Batch intelligence
DETAIL
-
Production release flow
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
Digital maturity: today and target
Scored out of 100 across six dimensions. The target is what PolfaWarszawa's own published ambition implies — not a perfect score.
- Data Integration 35 → 85
- Significant data silos exist between OT and IT systems; Digital Twin pilots limited to Starogard only
- Process Automation 40 → 90
- Paper-based batch records prevalent; manual labor-intensive operations in solid dosage units
- Real-Time Visibility 30 → 85
- Critical KPIs calculated offline in Excel; lack of unified dashboards across facilities
- Cybersecurity 45 → 90
- Air-gapped legacy equipment creates USB transfer risks; expanding cloud footprint with Microsoft increases attack surface
- Workforce Digital Skills 40 → 80
- Digital Hesitancy documented; "Paper Habit" deeply ingrained among long-tenured employees
- Sustainability Monitoring 35 → 85
- 2025 CO2 targets set but legacy systems cannot support real-time energy efficiency audits
Check this yourself
Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.
-
Self-assessment
Find Your LIMS
Answer a few questions about your lab and get a shortlist of LIMS that fit it.
-
Self-assessment
Data & AI Maturity
See how ready your data actually is for the AI work you're planning.
-
Market comparison
Digital Lab: Equipment & Integration Map
Which lab instruments connect to which systems, and where the gaps usually are.
-
Market comparison
Pharma Data Platform Use Cases — Ranked
Use cases ranked by how hard they are against what they're worth.
Think we've read this right?
Talk to usRelated reading
-
From Paper to Performance: Operational Efficiency and Compliance in Labs
Transform your QC lab with scalable digital solutions that embed compliance, boost efficiency, and deliver a future-ready competitive edge.
-
Accelerating lab and manufacturing operations with MTP – a modular approach
Among the various modular and plug-n-produce approaches, the Modular Type Package (MTP) approach has emerged as a game-changer.
-
OPC UA protocol support in embedded systems
OPC Unified Architecture (OPC UA) is a modern standard for data exchange, increasingly used in industrial environments.
-
Cybersecurity for industrial automation and control systems in Life Sciences
Pharma specific hardware and software development is far more complex than only Cybersecurity, but securely designed Product may address...
-
Digital Twin Maturity Model – self-assessment tool
Initially, defining what a digital twin even is seemed simple - we have a real product and its virtual counterpart, and we combine the two.
This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with PolfaWarszawa, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].